PMCB · CIK 0001157075 · operating
PharmaCyte Biotech, Inc. (PMCB) is a biological products, (no diagnostic substances) company incorporated in NV, listed on the Nasdaq. With a market capitalization of $7 million, PharmaCyte Biotech, Inc. is a micro-cap company. The stock currently trades at $0.70, up 1.78% today, with a 52-week range of $0.63–$1.84.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $3.19 | $3.19 | +277.2% | |
| 2024 | $-1.80 | $-1.80 | -718.2% | |
| 2023 | $-0.22 | $-0.22 | +18.5% | |
| 2022 | $-0.27 | $-0.27 | — | |
| 2021 | — | — | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — | |
| 2018 | — | — | — | |
| 2017 | — | — | — | |
| 2016 | — | — | — | |
| 2015 | — | — | — | |
| 2014 | — | $-0.05 | — | |
| 2013 | — | $0.00 | -100.0% | |
| 2012 | — | $0.01 | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2025-04-30 | 2025-08-11 | 0001683168-25-005821 | SEC ↗ |
| 2024-04-30 | 2024-08-13 | 0001683168-24-005575 | SEC ↗ |
| 2023-04-30 | 2023-07-31 | 0001683168-23-005175 | SEC ↗ |
| 2022-04-30 | 2022-07-28 | 0001683168-22-005189 | SEC ↗ |
| 2021-04-30 | 2021-08-10 | 0001683168-21-003377 | SEC ↗ |
| 2020-04-30 | 2020-08-13 | 0001683168-20-002680 | SEC ↗ |
| 2019-04-30 | 2019-08-13 | 0001683168-19-002559 | SEC ↗ |
| 2018-04-30 | 2018-07-20 | 0001683168-18-001994 | SEC ↗ |
| 2017-04-30 | 2017-07-27 | 0001683168-17-001881 | SEC ↗ |
| 2016-04-30 | 2016-07-29 | 0001019687-16-007057 | SEC ↗ |
| 2015-04-30 | 2015-07-29 | 0001019687-15-002894 | SEC ↗ |
| 2014-04-30 | 2014-08-04 | 0001019687-14-002942 | SEC ↗ |
| 2013-04-30 | 2013-07-29 | 0001157075-13-000010 | SEC ↗ |
| 2012-04-30 | 2012-08-14 | 0001262463-12-000335 | SEC ↗ |
| 2011-04-30 | 2011-08-15 | 0001262463-11-000129 | SEC ↗ |
| 2010-04-30 | 2010-12-29 | 0001262463-10-000148 | SEC ↗ |
| 2009-04-30 | 2009-08-13 | 0001262463-09-000065 | SEC ↗ |